These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34871556)

  • 1. Secreted protein acidic and rich in cysteine (SPARC) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) increments by the renin-angiotensin system induce renal fibrosis in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Ikemoto MJ; Kobara M; Nakata T
    Eur J Pharmacol; 2022 Jan; 914():174681. PubMed ID: 34871556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
    Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L; Duce B; Miric G; Sernia C
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted protein acidic and rich in cysteine expression after subtotal nephrectomy and blockade of the renin-angiotensin system.
    Wu LL; Cox A; Roe CJ; Dziadek M; Cooper ME; Gilbert RE
    J Am Soc Nephrol; 1997 Sep; 8(9):1373-82. PubMed ID: 9294828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Arrestin-Biased Agonist Targeting the Brain AT
    Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD
    Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension.
    Socha MJ; Manhiani M; Said N; Imig JD; Motamed K
    Am J Pathol; 2007 Oct; 171(4):1104-12. PubMed ID: 17717147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice.
    Wang Q; Schäfer SC; Haefliger JA; Maillard MP; Alonso F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local angiotensin II aggravates cardiac remodeling in hypertension.
    Xu J; Carretero OA; Liao TD; Peng H; Shesely EG; Xu J; Liu TS; Yang JJ; Reudelhuber TL; Yang XP
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1328-38. PubMed ID: 20833959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
    Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chung TH; Lin SZ; Chang NC
    J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension.
    Uijl E; Ren L; Mirabito Colafella KM; van Veghel R; Garrelds IM; Domenig O; Poglitsch M; Zlatev I; Kim JB; Huang S; Melton L; Hoorn EJ; Foster D; Danser AHJ
    Clin Sci (Lond); 2021 Jan; 135(2):259-274. PubMed ID: 33404046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Hypertension; 1994 Aug; 24(2):195-204. PubMed ID: 8039844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC).
    McCurdy S; Baicu CF; Heymans S; Bradshaw AD
    J Mol Cell Cardiol; 2010 Mar; 48(3):544-9. PubMed ID: 19577572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
    Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
    J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE; Pokharel S; Sharma U; Carretero OA
    J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.